BioAtla, Inc.BCABNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 3Y Ago
-0.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2024-39.17%
202330.73%
202236.16%
2021192.35%
2020-23.10%
2019-1.47%
20180.00%